N. Rouyer

发表

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

Pierre-Marie Martin, Carole Mathelin, Fabrice André, 2011, Breast Cancer Research and Treatment.

River Basin Network on Water Framework Directive and Agriculture

M. Valente, V. Iacobellis, F. Falaschi, 2013 .

Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

P. Chambon, P. Basset, M. Rio, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of monoclonal antibodies against stromelysin‐3 and their use to evaluate stromelysin‐3 levels in breast carcinoma by semi‐quantitative immunohistochemistry

P. Basset, Y. Lutz, M. Rio, 1995, International journal of cancer.

Stromelysin‐3 in stromal tissue as a control factor in breast cancer behavior

P. Chambon, P. Basset, M. Rio, 1994 .

Comparative expression of the SPARC and stromelysin-3 genes in mammary tumours

P. Chambon, O. Podhajcer, P. Basset, 1996 .

Production and characterization of monoclonal antibodies recognising defined regions of the human oestrogen receptor.

D. Metzger, S. Ali, Y. Lutz, 1993, Hybridoma.

[Value of stereotactic breast core biopsy in patients with atypical ductal hyperplasia].

C. Tourasse, N. Rouyer, C. Donné, 2008, Journal de radiologie.

Human resident peritoneal macrophages: phenotype and biology

M. Hummel, B. Duclos, J. Bergerat, 1994, British journal of haematology.

Stromelysin-3 and other stromelysins in breast cancer: importance of epithelial-stromal interactions during tumor progression.

A. Noël, P. Basset, M. Rio, 1996, Cancer treatment and research.

The Tissue Inhibitor of Metalloproteinases-3 Gene in Breast Carcinoma: Identification of Multiple Polyadenylation Sites and a Stromal Pattern of Expression

P. Basset, C. Tomasetto, M. Rio, 1995, Molecular medicine.

The FMR–1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation

J. Mandel, Y. Lutz, J. Bellocq, 1993, Nature Genetics.

Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.

M. Loriot, P. Chambon, P. Basset, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Stromelysin-3 gene expression in human cancer: an overview.

P. Chambon, P. Basset, M. Rio, 1994, Invasion & metastasis.

Bronchopulmonary distress associated with toxic epidermal necrolysis

J. Timsit, H. Carsin, N. Rouyer, 2005, Intensive Care Medicine.

A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence.

P. Basset, M. Mattei, C. Tomasetto, 1995, Cancer research.

High levels of stromelysin‐3 correlate with poor prognosis in patients with breast carcinoma

M. Duffy, P. Basset, Y. Lutz, 1996, International journal of cancer.

Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.

Catherine, P. Basset, J. Abecassis, 1993, Cancer research.

[Value of vacuum assisted biopsies under sonography guidance: results from a multicentric study of 650 lesions].

C. Tourasse, N. Rouyer, P. Michenet, 2006, Journal de radiologie.

Correlation of immunocytochemistry and hybrid capture for human papillomavirus detection in cervical smears

P. Brousset, N. Rouyer, V. Butet, 2004, Diagnostic Cytopathology.